Literature DB >> 10762329

The retrograde inhibition of IPSCs in rat cerebellar purkinje cells is highly sensitive to intracellular Ca2+.

M Glitsch1, P Parra, I Llano.   

Abstract

The Ca2+-dependent retrograde inhibition of inhibitory postsynaptic currents (depolarization-induced-suppression of inhibition; DSI) was investigated using fura-2 Ca2+ measurements and whole-cell patch-clamp recordings in rat cerebellar Purkinje cells. DSI was studied in cells loaded with different concentrations of the Ca2+ chelators BAPTA and EGTA. A concentration of 40 mM BAPTA was required to significantly interfere with DSI, whereas 10 mM BAPTA was almost ineffective. 40 mM EGTA reduced DSI, but was less effective than 40 mM BAPTA. Ratiometric Ca2+ measurements indicated that the extent of DSI depended critically on the changes in intracellular calcium ([Ca2+]i). The relationship between DSI and peak Delta[Ca2+]i could be approximated by a hyperbolic function, with apparent half-saturation concentrations of 200 and 40 nM for dendritic and somatic [Ca2+]i, respectively. It is suggested that DSI is due to somatodendritic exocytosis of a retrograde messenger, and that this exocytosis is highly sensitive to [Ca2+]i.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10762329     DOI: 10.1046/j.1460-9568.2000.00994.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  10 in total

1.  Photolysis-induced suppression of inhibition in rat hippocampal CA1 pyramidal neurons.

Authors:  J Wang; R S Zucker
Journal:  J Physiol       Date:  2001-06-15       Impact factor: 5.182

2.  Short-term retrograde inhibition of GABAergic synaptic currents in rat Purkinje cells is mediated by endogenous cannabinoids.

Authors:  Marco A Diana; Carole Levenes; Ken Mackie; Alain Marty
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

3.  The cannabinoid CB1 receptor mediates retrograde signals for depolarization-induced suppression of inhibition in cerebellar Purkinje cells.

Authors:  Takayuki Yoshida; Kouichi Hashimoto; Andreas Zimmer; Takashi Maejima; Kenji Araishi; Masanobu Kano
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

4.  Chemokine fractalkine/CX3CL1 negatively modulates active glutamatergic synapses in rat hippocampal neurons.

Authors:  Davide Ragozzino; Silvia Di Angelantonio; Flavia Trettel; Cristina Bertollini; Laura Maggi; Cornelius Gross; Israel F Charo; Cristina Limatola; Fabrizio Eusebi
Journal:  J Neurosci       Date:  2006-10-11       Impact factor: 6.167

Review 5.  Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE).

Authors:  Marco A Diana; Alain Marty
Journal:  Br J Pharmacol       Date:  2004-04-20       Impact factor: 8.739

6.  Retroinhibition of presynaptic Ca2+ currents by endocannabinoids released via postsynaptic mGluR activation at a calyx synapse.

Authors:  Christopher Kushmerick; Gareth D Price; Holger Taschenberger; Nagore Puente; Robert Renden; Jacques I Wadiche; Robert M Duvoisin; Pedro Grandes; Henrique von Gersdorff
Journal:  J Neurosci       Date:  2004-06-30       Impact factor: 6.167

7.  Mechanisms Underlying Enhancement of Spontaneous Glutamate Release by Group I mGluRs at a Central Auditory Synapse.

Authors:  Kang Peng; Xiaoyu Wang; Yuan Wang; Dainan Li; Hai Huang; Yong Lu
Journal:  J Neurosci       Date:  2020-08-12       Impact factor: 6.167

8.  Addictive neurons.

Authors:  Sodikdjon A Kodirov
Journal:  Ther Targets Neurol Dis       Date:  2017-01-30

Review 9.  Beyond "all-or-nothing" climbing fibers: graded representation of teaching signals in Purkinje cells.

Authors:  Farzaneh Najafi; Javier F Medina
Journal:  Front Neural Circuits       Date:  2013-07-02       Impact factor: 3.492

10.  AMPA receptor-mediated presynaptic inhibition at cerebellar GABAergic synapses: a characterization of molecular mechanisms.

Authors:  Shin'Ichiro Satake; Fumihito Saitow; Dmitri Rusakov; Shiro Konishi
Journal:  Eur J Neurosci       Date:  2004-05       Impact factor: 3.386

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.